We found that breast cancers high in CCNE1 had significantly worse prognosis in breast cancers (Figure 2B), and that poor prognosis was also predicted by high CCNE1 expression in the subset of cancers that were not genome doubled (Figure 2C). The gene discussed is CCNE1; the disease is breast cancer.